Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanomaGene Ther

J C Steele, A Rao, J R Marsden
A blank post.

Backlinks

1.

J C Steele, A Rao, J R Marsden. Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanomaGene Ther. 2011.